| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 81.07B | 81.37B | 81.59B | 78.08B | 74.71B | 71.40B |
| Gross Profit | 38.52B | 38.79B | 37.05B | 35.72B | 34.72B | 33.89B |
| EBITDA | 6.28B | 5.83B | 7.24B | 6.57B | 6.67B | 6.63B |
| Net Income | 2.92B | 2.27B | 3.56B | 3.11B | 3.37B | 3.54B |
Balance Sheet | ||||||
| Total Assets | 56.36B | 56.08B | 54.65B | 52.78B | 50.64B | 46.83B |
| Cash, Cash Equivalents and Short-Term Investments | 14.53B | 12.30B | 9.46B | 9.52B | 5.31B | 6.15B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 15.24B | 15.92B | 15.53B | 15.81B | 15.65B | 11.48B |
| Stockholders Equity | 41.12B | 40.16B | 39.12B | 36.96B | 34.99B | 35.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.41B | 1.78B | 5.71B | 35.53M | -540.55M |
| Operating Cash Flow | 0.00 | 6.30B | 4.29B | 8.58B | 2.53B | 1.59B |
| Investing Cash Flow | 0.00 | -2.15B | -3.00B | -3.05B | -2.64B | -2.41B |
| Financing Cash Flow | 0.00 | -1.31B | -1.36B | -1.32B | -734.96M | -733.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.75B | 13.29 | ― | 2.19% | 15.14% | 17.01% | |
79 Outperform | ¥31.81B | 13.05 | ― | 3.77% | 17.14% | 8.81% | |
72 Outperform | ¥227.26B | 31.36 | ― | 0.64% | 53.35% | 107.20% | |
71 Outperform | ¥32.72B | 14.68 | 6.70% | 3.84% | -0.27% | -36.14% | |
66 Neutral | ¥32.93B | 12.00 | ― | 0.95% | 15.82% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥32.86B | 13.61 | ― | 1.73% | 7.61% | 57.19% |